Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
13
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Mendelsohn Alan | EVP & CMO | 6 | $9.0K | $0 | 2023-08-20 |
| Lucchese Joseph | Executive VP & CFO | 5 | $0 | $0 | 2023-08-20 |
| Koconis John | Chief Executive Officer | 6 | $7.6K | $0 | 2023-08-20 |
| Gaal Lubor | Director | 5 | $0 | $0 | 2023-04-15 |
| Pirozzi Gianluca | Director | 6 | $0 | $0 | 2023-04-15 |
| Sitar Edward J | Director | 8 | $6.9K | $0 | 2023-04-15 |
| Cohen David E | Director | 5 | $0 | $0 | 2023-04-15 |
| Rome Zachary | Executive VP, COO and Sec. | 6 | $0 | $0 | 2022-03-04 |
| TardiMed Sciences LLC | 10% Owner | 25 | $0 | $2.32M | 2021-09-02 |
| Bragg Kimberly | Controller | 1 | $0 | $0 | 2020-06-08 |
| Stocum Michael | Director | 1 | $0 | $0 | 2020-06-08 |
| BROENNIMAN LINDA A | Director | 1 | $0 | $0 | 2020-06-08 |
| Tavakkol Amir | Chief Scientific Officer | 1 | $0 | $0 | 2020-05-18 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Lucchese Joseph | EVP & CFO | A Award | 2023-08-20 | 2023-08-22 | 35,193 | — | $0 | 35,193 | SEC↗ |
| Mendelsohn Alan | EVP & CMO | A Award | 2023-08-20 | 2023-08-22 | 35,193 | — | $0 | 35,393 | SEC↗ |
| Koconis John | CEO & Chairman | A Award | 2023-08-20 | 2023-08-22 | 70,385 | — | $0 | 70,785 | SEC↗ |
| Lucchese Joseph | EVP & CFO | A Award deriv | 2023-04-15 | 2023-04-18 | 22,505 | — | $0 | 22,505 | SEC↗ |
| Cohen David E | Director | A Award deriv | 2023-04-15 | 2023-04-18 | 4,100 | — | $0 | 4,100 | SEC↗ |
| Sitar Edward J | Director | A Award deriv | 2023-04-15 | 2023-04-18 | 5,327 | — | $0 | 5,327 | SEC↗ |
| Pirozzi Gianluca | Director | A Award deriv | 2023-04-15 | 2023-04-18 | 4,100 | — | $0 | 4,100 | SEC↗ |
| Mendelsohn Alan | EVP & CMO | A Award deriv | 2023-04-15 | 2023-04-18 | 22,505 | — | $0 | 22,505 | SEC↗ |
| Gaal Lubor | Director | A Award deriv | 2023-04-15 | 2023-04-18 | 4,100 | — | $0 | 4,100 | SEC↗ |
| Koconis John | CEO & Chairman | A Award deriv | 2023-04-15 | 2023-04-18 | 45,010 | — | $0 | 45,010 | SEC↗ |
| Cohen David E | Director | A Award | 2023-04-15 | 2023-04-18 | 4,100 | — | $0 | 6,100 | SEC↗ |
| Sitar Edward J | Director | A Award | 2023-04-15 | 2023-04-18 | 5,327 | — | $0 | 11,127 | SEC↗ |
| Pirozzi Gianluca | Director | A Award | 2023-04-15 | 2023-04-18 | 4,100 | — | $0 | 6,100 | SEC↗ |
| Gaal Lubor | Director | A Award | 2023-04-15 | 2023-04-18 | 4,100 | — | $0 | 6,100 | SEC↗ |
| Sitar Edward J | Director | A Award | 2022-12-15 | 2022-12-16 | 2,500 | $1.63 | $4.1K | 5,800 | SEC↗ |
| Gaal Lubor | Director | A Award deriv | 2022-04-15 | 2022-04-19 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Pirozzi Gianluca | Director | A Award deriv | 2022-04-15 | 2022-04-19 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Sitar Edward J | Director | A Award deriv | 2022-04-15 | 2022-04-19 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Cohen David E | Director | A Award deriv | 2022-04-15 | 2022-04-19 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Koconis John | CEO & Chairman of the Board | A Award deriv | 2022-04-15 | 2022-04-19 | 600,000 | — | $0 | 600,000 | SEC↗ |
| Mendelsohn Alan | Chief Medical Officer | A Award deriv | 2022-04-15 | 2022-04-19 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Lucchese Joseph | CFO,EVP,Secretary&Treasurer | A Award deriv | 2022-04-15 | 2022-04-19 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Gaal Lubor | Director | A Award | 2022-04-15 | 2022-04-19 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Pirozzi Gianluca | Director | A Award | 2022-04-15 | 2022-04-19 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Sitar Edward J | Director | A Award | 2022-04-15 | 2022-04-19 | 150,000 | — | $0 | 165,000 | SEC↗ |
| Cohen David E | Director | A Award | 2022-04-15 | 2022-04-19 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Rome Zachary | Director | D To issuer deriv | 2022-03-04 | 2022-04-15 | 52,884 | — | $0 | 79,326 | SEC↗ |
| Rome Zachary | Director | M Exercise deriv | 2022-03-04 | 2022-04-15 | 79,326 | — | $0 | 0 | SEC↗ |
| Rome Zachary | Director | F Tax w/h | 2022-03-04 | 2022-04-15 | 19,630 | $0.28 | $5.5K | 59,696 | SEC↗ |
| Rome Zachary | Director | M Exercise | 2022-03-04 | 2022-04-15 | 79,326 | $0.01 | $793 | 79,326 | SEC↗ |
| Koconis John | CEO & President | P Buy | 2021-12-15 | 2021-12-16 | 20,000 | $0.38 | $7.6K | 20,000 | SEC↗ |
| Sitar Edward J | Director | P Buy | 2021-11-23 | 2021-11-24 | 15,000 | $0.46 | $6.9K | 15,000 | SEC↗ |
| Mendelsohn Alan | Chief Medical Officer | P Buy | 2021-11-23 | 2021-11-24 | 10,000 | $0.47 | $4.7K | 10,000 | SEC↗ |
| Lucchese Joseph | CFO, Executive VP & Treasure | A Award deriv | 2021-09-27 | 2021-09-29 | 361,163 | — | $0 | 361,163 | SEC↗ |
| Koconis John | CEO & President | A Award deriv | 2021-09-14 | 2021-09-16 | 890,000 | — | $0 | 890,000 | SEC↗ |
| Rome Zachary | COO, Executive VP & Secretar | A Award deriv | 2021-09-14 | 2021-09-16 | 561,000 | — | $0 | 561,000 | SEC↗ |
| TardiMed Sciences LLC | 10% Owner | S Sale | 2021-09-02 | 2021-09-02 | 225,000 | $0.94 | $211.5K | 3,508,567 | SEC↗ |
| TardiMed Sciences LLC | 10% Owner | S Sale | 2021-09-01 | 2021-09-01 | 150,500 | $0.92 | $138.5K | 3,733,567 | SEC↗ |
| TardiMed Sciences LLC | 10% Owner | S Sale | 2021-08-31 | 2021-09-01 | 150,000 | $0.91 | $136.5K | 3,884,067 | SEC↗ |
| TardiMed Sciences LLC | 10% Owner | S Sale | 2021-08-30 | 2021-09-01 | 100,000 | $0.93 | $93.0K | 4,034,067 | SEC↗ |
| TardiMed Sciences LLC | 10% Owner | S Sale | 2021-08-26 | 2021-08-26 | 100,000 | $0.92 | $92.0K | 4,134,067 | SEC↗ |
| TardiMed Sciences LLC | 10% Owner | S Sale | 2021-08-25 | 2021-08-26 | 100,000 | $0.91 | $91.0K | 4,234,067 | SEC↗ |
| TardiMed Sciences LLC | 10% Owner | S Sale | 2021-08-24 | 2021-08-26 | 100,000 | $0.93 | $93.0K | 4,334,067 | SEC↗ |
| TardiMed Sciences LLC | 10% Owner | S Sale | 2021-08-20 | 2021-08-20 | 50,000 | $0.91 | $45.5K | 4,434,067 | SEC↗ |
| TardiMed Sciences LLC | 10% Owner | S Sale | 2021-08-19 | 2021-08-20 | 50,000 | $0.95 | $47.5K | 4,484,067 | SEC↗ |
| TardiMed Sciences LLC | 10% Owner | S Sale | 2021-08-18 | 2021-08-20 | 75,000 | $1.00 | $75.0K | 4,534,067 | SEC↗ |
| Cohen David E | Director | A Award deriv | 2021-07-01 | 2021-07-06 | 71,893 | — | $0 | 71,893 | SEC↗ |
| Gaal Lubor | Director | A Award deriv | 2021-07-01 | 2021-07-06 | 71,893 | — | $0 | 71,893 | SEC↗ |
| Mendelsohn Alan | Chief Medical Officer | A Award deriv | 2021-07-01 | 2021-07-06 | 347,991 | — | $0 | 347,991 | SEC↗ |
| Pirozzi Gianluca | Director | A Award deriv | 2021-07-01 | 2021-07-06 | 47,623 | — | $0 | 47,623 | SEC↗ |
| Sitar Edward J | Director | A Award deriv | 2021-07-01 | 2021-07-06 | 47,623 | — | $0 | 47,623 | SEC↗ |
| TardiMed Sciences LLC | 10% Owner | S Sale | 2021-06-15 | 2021-06-15 | 28,450 | $1.26 | $35.8K | 4,609,067 | SEC↗ |
| TardiMed Sciences LLC | 10% Owner | S Sale | 2021-06-14 | 2021-06-15 | 146,465 | $1.27 | $186.0K | 4,637,517 | SEC↗ |
| TardiMed Sciences LLC | 10% Owner | S Sale | 2021-06-10 | 2021-06-10 | 185,229 | $1.26 | $233.4K | 4,783,982 | SEC↗ |
| TardiMed Sciences LLC | 10% Owner | S Sale | 2021-06-09 | 2021-06-10 | 96,481 | $1.27 | $122.5K | 4,969,211 | SEC↗ |
| TardiMed Sciences LLC | 10% Owner | S Sale | 2021-06-08 | 2021-06-10 | 305,540 | $1.29 | $394.1K | 5,065,692 | SEC↗ |
| TardiMed Sciences LLC | 10% Owner | S Sale | 2021-06-02 | 2021-06-02 | 9,879 | $1.26 | $12.4K | 5,371,232 | SEC↗ |
| TardiMed Sciences LLC | 10% Owner | S Sale | 2021-06-01 | 2021-06-02 | 8,670 | $1.26 | $10.9K | 5,381,111 | SEC↗ |
| TardiMed Sciences LLC | 10% Owner | S Sale | 2021-05-28 | 2021-06-02 | 47,736 | $1.27 | $60.6K | 5,389,781 | SEC↗ |
| Mendelsohn Alan | Chief Medical Officer | P Buy | 2021-03-03 | 2021-05-13 | 1,988 | $2.17 | $4.3K | 1,988 | SEC↗ |
| TardiMed Sciences LLC | 10% Owner | S Sale | 2020-09-16 | 2020-09-16 | 100,694 | $1.03 | $103.7K | 5,437,517 | SEC↗ |
| TardiMed Sciences LLC | 10% Owner | S Sale | 2020-09-15 | 2020-09-16 | 87,060 | $1.03 | $89.7K | 5,538,211 | SEC↗ |
| TardiMed Sciences LLC | 10% Owner | S Sale | 2020-09-14 | 2020-09-16 | 455 | $1.03 | $469 | 5,625,271 | SEC↗ |
| TardiMed Sciences LLC | 10% Owner | S Sale | 2020-09-11 | 2020-09-14 | 7,483 | $1.03 | $7.7K | 5,625,726 | SEC↗ |
| TardiMed Sciences LLC | 10% Owner | S Sale | 2020-09-10 | 2020-09-14 | 32,943 | $1.04 | $34.3K | 5,633,209 | SEC↗ |
| Bragg Kimberly | Controller | A Award deriv | 2020-06-08 | 2020-06-09 | 38,833 | — | $0 | 38,833 | SEC↗ |
| Pirozzi Gianluca | Director | A Award deriv | 2020-06-08 | 2020-06-09 | 24,270 | — | $0 | 24,270 | SEC↗ |
| Sitar Edward J | Director | A Award deriv | 2020-06-08 | 2020-06-09 | 24,270 | — | $0 | 24,270 | SEC↗ |
| Lucchese Joseph | Executive VP & CFO | A Award deriv | 2020-06-08 | 2020-06-09 | 97,083 | — | $0 | 97,083 | SEC↗ |
| Stocum Michael | Director | A Award deriv | 2020-06-08 | 2020-06-09 | 24,270 | — | $0 | 24,270 | SEC↗ |
| BROENNIMAN LINDA A | Director | A Award deriv | 2020-06-08 | 2020-06-09 | 24,270 | — | $0 | 24,270 | SEC↗ |
| TardiMed Sciences LLC | 10% Owner | J Other deriv | 2020-05-18 | 2020-05-20 | 1,821 | — | $0 | 1,821 | SEC↗ |
| Tavakkol Amir | Chief Scientific Officer | A Award deriv | 2020-05-18 | 2020-05-20 | 8,184 | — | $0 | 8,184 | SEC↗ |
| Koconis John | Chief Executive Officer | A Award deriv | 2020-05-18 | 2020-05-20 | 209,646 | — | $0 | 209,646 | SEC↗ |
| Rome Zachary | Executive VP, COO and Sec. | A Award deriv | 2020-05-18 | 2020-05-20 | 132,209 | — | $0 | 132,209 | SEC↗ |
| TardiMed Sciences LLC | 10% Owner | J Other | 2020-05-18 | 2020-05-20 | 5,666,152 | — | $0 | 5,666,152 | SEC↗ |